EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Whole-exome sequencing of rectal neuroendocrine tumors

Yuanliang Li iD, Yiying Guo iD, Zixuan Cheng iD, Chao Tian, Yingying Chen, Ruao Chen, Fuhuan Yu, Yanfen Shi, Fei Su, Shuhua Zhao, Zhizheng Wang, Jie Luo und 1 weitere

Endocrine-Related Cancer · 16.01.2023 · 30 (9)

DOI: 10.1530/erc-22-0257 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine-Related Cancer, erschienen am 16.01.2023. Verfasst von Yuanliang Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Oncology, China-Japan Friendship Hospital, Beijing University of Chinese Medicine, Beijing, China. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Rectal Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The genetic characteristics of rectal neuroendocrine tumors (R-NETs) were poorly understood. Depicting the genetic characteristics may provide a biological basis for prognosis prediction and novel treatment development. Tissues of 18 R-NET patients were analyzed using whole-exome sequencing. The median tumor mutation burden (TMB) and microsatellite instability (MSI) were 1.15 Muts/MB (range, 0.03–23.28) and 0.36 (range, 0.00–10.97), respectively. Genes involved in P53 signaling, PI3K-AKT signaling, DNA damage repair, WNT signaling, etc. were frequently altered. Higher TMB ( P = 0.078), higher CNV ( P = 0.110), somatic mutation of CCDC168 ( P = 0.049), HMCN1 ( P = 0.040), MYO10 ( P = 0.007), and amplification of ZC3H13 ( P < 0.001) were associated with shorter OS. Potentially targetable gene alterations (PTGAs) were seen in 72% of the patients. FGFR1 amplification (22%) was the most common PTGA followed by BARD1 and BRCA2 mutation (each 17%). As for gene variations associated with the efficacy of immune checkpoint blockade (ICB), FAT1 alteration (39%) and PTEN depletion (28%) were commonly observed. In conclusion, frequently altered oncogenic pathways might contribute to the development and progression of R-NETs. Gene alterations significantly associated with prognosis might be potential novel targets. Targeted therapy might be a promising strategy as targetable alterations were prevalent in R-NETs. FAT1 alteration and PTEN depletion might be the main genetic alterations influencing the response to ICB besides overall low TMB and MSI in R-NETs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsRectal NeoplasmsHumansExome SequencingPhosphatidylinositol 3-KinasesMutationBiomarkers, TumorHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

immune checkpoint blockadeprognosisrectal neuroendocrine tumorstargeted therapywhole-exome sequencing

Substanzen

Phosphatidylinositol 3-KinasesBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Integrative Oncology, China-Japan Friendship Hospital, Beijing University of Chinese Medicine, Beijing, China.
  • Department of Integrative Oncology, China-Japan Friendship Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Department of Pathology, China-Japan Friendship Hospital, Beijing, China.
  • Department of Integrative Oncology, China-Japan Friendship Hospital, Beijing, China.
  • Department of Biological Information Research, HaploX Biotechnology Co., Ltd, Shenzhen, Guangdong, China.
  • Academic Department, HaploX Biotechnology, Co., Ltd, Shenzhen, Guangdong, China.

ORCID-Profile: Yuanliang Li, Yiying Guo, Zixuan Cheng, Huangying Tan

Zitieren

APA

Li, Y., Guo, Y., Cheng, Z., Tian, C., Chen, Y., Chen, R., Yu, F., Shi, Y., Su, F., Zhao, S., Wang, Z., Luo, J., & Tan, H. (2023). Whole-exome sequencing of rectal neuroendocrine tumors. Endocrine-Related Cancer, 30(9). https://doi.org/10.1530/erc-22-0257

Vancouver

Li Y, Guo Y, Cheng Z, Tian C, Chen Y, Chen R, et al. Whole-exome sequencing of rectal neuroendocrine tumors. Endocrine-Related Cancer. 2023;30(9). doi:10.1530/erc-22-0257

BibTeX
@article{Li2023,
  author = {Li, Yuanliang and Guo, Yiying and Cheng, Zixuan and Tian, Chao and Chen, Yingying and Chen, Ruao and Yu, Fuhuan and Shi, Yanfen and Su, Fei and Zhao, Shuhua and Wang, Zhizheng and Luo, Jie and Tan, Huangying},
  title = {Whole-exome sequencing of rectal neuroendocrine tumors},
  journal = {Endocrine-Related Cancer},
  year = {2023},
  volume = {30},
  number = {9},
  doi = {10.1530/erc-22-0257}
}
Kostenlos starten →